Compare Mutual Funds
Risk
Very High
-
Rating
-
-
Min SIP Amount
₹100
-
Expense Ratio
2.2
-
NAV
₹21.51
-
Fund Started
14 Sep 2023
-
Fund Size
₹2611.33 Cr
-
Exit Load
Exit load of 1%, if redeemed within 30 days.
-
1 Year
17.93%
-
3 Year
-
-
5 Year
-
-
Equity
97.25%
-
Cash
2.75%
-
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 9.96% |
Divi's Laboratories Ltd. | 7.16% |
Max Healthcare Institute Ltd. | 5.57% |
Lupin Ltd. | 5.26% |
Cipla Ltd. | 5.19% |
Aster DM Healthcare Ltd. | 5.05% |
Acutaas Chemicals Ltd. | 4.58% |
Alkem Laboratories Ltd. | 4.00% |
Anthem Biosciences Ltd. | 3.81% |
Ipca Laboratories Ltd. | 3.53% |
-
Name
-
-
Start Date
-
-
Description
The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
-
Launch Date
14 Sep 2023
-
